Pathogenesis and therapy of cytomegalovirus (CMV)-associated lung disease following anti-CD3 monoclonal antibody treatment in mice with persistent murine CMV in the salivary glands.
Tanaka
K
K
Department of Virology, Kyushu University, Fukuoka, Japan.
Koga
Y
Y
Kimura
G
G
Nomoto
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000633:toxicity*; D017252:CD3 Complex / Q000276:immunology*; D002478:Cells, Cultured; D016572:Cyclosporine / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D004622:Embryo, Mammalian; D015774:Ganciclovir / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012469:Salivary Glands / Q000821:virology*; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D016572:Cyclosporine; D015774:Ganciclovir